Citius Pharmaceuticals, Inc. — Cash Flow Charts
16 years of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-9.5% -$2M
$-27M
Free Cash Flow↓-9.5% -$2M
$-27M
Investing Cash Flow↑+85.6% +$34M
$-6M
Financing Cash Flow↓-72.4% -$87M
$33M
Capex↑+226.3% +$5K
$7K
Stock-Based Comp↑+644.8% +$9M
$11M
Debt Issued↑+29887.7% +$10M
$10M
Debt Repaid
$30K
D&A↑+69.7% +$588
$1K
SBC Allocated Expense↑+644.8% +$9M
$11M
SBC Unrecognized Cost
$1M